Skip to main content
. 2021 Jan 27;38:88. doi: 10.11604/pamj.2021.38.88.21370

Table 2.

survival outcome according to biologic subtypes

Molecular subtype Mean DFS (months) SE P=0.023
Luminal A 59,329 2,227
Luminal B 40,036 2,632
HER2+ 89,054 7,539
TNBC 94,608 6,222
Overall 90,464 5,964

DFS: disease free survival; SE: standard error; HER2: human epidermal growth factor receptor 2; TNBC: triple negative breast cancer